300314 戴维医疗
已收盘 06-17 15:00:00
资讯
新帖
简况
戴维医疗最新公告:2023年度权益分派10派1.8元 股权登记日6月18日
证券之星 · 06-11
戴维医疗最新公告:2023年度权益分派10派1.8元 股权登记日6月18日
戴维医疗(300314.SZ)2023年年度权益分派:每10股派1.80元 6月18日股权登记
智通财经 · 06-11
戴维医疗(300314.SZ)2023年年度权益分派:每10股派1.80元 6月18日股权登记
戴维医疗:截止到2024年5月20日,公司股东总户数约为20400户左右
证券之星 · 05-27
戴维医疗:截止到2024年5月20日,公司股东总户数约为20400户左右
戴维医疗(300314)5月20日股东户数2.04万户,较上期增加16.61%
证券之星 · 05-27
戴维医疗(300314)5月20日股东户数2.04万户,较上期增加16.61%
戴维医疗涨8.75%,开源证券一个月前给出“买入”评级
证券之星 · 05-20
戴维医疗涨8.75%,开源证券一个月前给出“买入”评级
戴维医疗(300314)5月17日主力资金净卖出1225.75万元
证券之星 · 05-17
戴维医疗(300314)5月17日主力资金净卖出1225.75万元
戴维医疗:子公司产品获得医疗器械注册证 有利于丰富公司产品线
中国财富通 · 05-16
戴维医疗:子公司产品获得医疗器械注册证 有利于丰富公司产品线
戴维医疗最新公告:全资子公司一次性使用电动肛肠吻合器获得医疗器械注册证
证券之星 · 05-16
戴维医疗最新公告:全资子公司一次性使用电动肛肠吻合器获得医疗器械注册证
戴维医疗(300314.SZ)子公司维尔凯迪取得一项医疗器械注册证
智通财经 · 05-16
戴维医疗(300314.SZ)子公司维尔凯迪取得一项医疗器械注册证
戴维医疗(300314)5月15日主力资金净卖出995.65万元
证券之星 · 05-15
戴维医疗(300314)5月15日主力资金净卖出995.65万元
戴维医疗:公司参股子公司希瑞科技所从事的是干细胞存储行业,主要涉及新生儿脐带、胎盘干细胞的储存服务
证券之星 · 05-14
戴维医疗:公司参股子公司希瑞科技所从事的是干细胞存储行业,主要涉及新生儿脐带、胎盘干细胞的储存服务
戴维医疗创60日新高,开源证券四周前给出“买入”评级
证券之星 · 05-08
戴维医疗创60日新高,开源证券四周前给出“买入”评级
5月8日戴维医疗涨停分析:干细胞,基因测序,医疗器械概念热股
证券之星 · 05-08
5月8日戴维医疗涨停分析:干细胞,基因测序,医疗器械概念热股
异动快报:戴维医疗(300314)5月8日9点31分触及涨停板
证券之星 · 05-08
异动快报:戴维医疗(300314)5月8日9点31分触及涨停板
戴维医疗获得发明专利授权:“一种冷冻装置及医用压缩机”
证券之星 · 04-23
戴维医疗获得发明专利授权:“一种冷冻装置及医用压缩机”
暂无数据
公司概况
公司名称:
宁波戴维医疗器械股份有限公司
所属行业:
专用设备制造业
上市日期:
2012-05-08
主营业务:
宁波戴维医疗器械股份有限公司主营业务为儿产科保育设备以及微创外科手术器械。公司主要产品为婴儿培养箱、婴儿辐射保暖台、新生儿黄疸治疗设备、黄疸检测设备、微创外科手术器械。公司被国家工信部认定为“制造业单项冠军培育企业”。公司是国内同行业首批通过CMDC认证、CE认证的企业之一,多项产品在国内外展会获奖,“婴儿培养箱输氧控制技术”、“高精度可控湿度技术”、“婴儿培养箱低噪音技术”和“光照治疗温度控制合成技术”等技术均为国内领先或国内首创。
发行价格:
20.00
{"stockData":{"symbol":"300314","market":"SZ","secType":"STK","nameCN":"戴维医疗","latestPrice":10.85,"timestamp":1718607795000,"preClose":10.97,"halted":0,"volume":2220046,"delay":0,"floatShares":189000000,"shares":288000000,"eps":0.4712,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.12,"latestTime":"06-17 15:00:00","open":10.85,"high":10.97,"low":10.73,"amount":24077200,"amplitude":0.0219,"askPrice":10.86,"askSize":73,"bidPrice":10.85,"bidSize":19,"shortable":0,"etf":0,"ttmEps":0.4712,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1718674200000},"adr":0,"adjPreClose":10.97,"symbolType":"stock","openAndCloseTimeList":[[1718587800000,1718595000000],[1718600400000,1718607600000]],"highLimit":12.07,"lowLimit":9.87,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":288000000,"pbRate":2.63,"roa":"--","roe":"3.22%","epsLYR":0.51,"committee":-0.061654,"marketValue":3125000000,"floatMarketCap":2055000000,"peRate":23.026316,"changeRate":-0.0109,"turnoverRate":0.0117,"status":1},"requestUrl":"/m/hq/s/300314/tweets","defaultTab":"tweets","newsList":[{"id":"2442675643","title":"戴维医疗最新公告:2023年度权益分派10派1.8元 股权登记日6月18日","url":"https://stock-news.laohu8.com/highlight/detail?id=2442675643","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442675643?lang=zh_cn&edition=full","pubTime":"2024-06-11 19:51","pubTimestamp":1718106678,"startTime":"0","endTime":"0","summary":"戴维医疗公布2023年年度权益分派实施公告,公司2023年年度权益分派方案为:向全体股东每10股派1.8元人民币现金(含税)。本次权益分派股权登记日为:2024年6月18日。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061100026932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300314","BK0042","BK0048","BK0251"],"gpt_icon":0},{"id":"2442368039","title":"戴维医疗(300314.SZ)2023年年度权益分派:每10股派1.80元 6月18日股权登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2442368039","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442368039?lang=zh_cn&edition=full","pubTime":"2024-06-11 18:00","pubTimestamp":1718100027,"startTime":"0","endTime":"0","summary":"智通财经APP讯,戴维医疗(300314.SZ)发布公告,公司2023年年度权益分派方案为:以公司现有总股本为基数,向全体股东每10股派1.80元人民币现金(含税),本次权益分派股权登记日为:2024年06月18日,除权除息日为:2024年06月19日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1133581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","BK0048","BK0046","300314","BK0042"],"gpt_icon":0},{"id":"2438806888","title":"戴维医疗:截止到2024年5月20日,公司股东总户数约为20400户左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2438806888","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438806888?lang=zh_cn&edition=full","pubTime":"2024-05-27 17:03","pubTimestamp":1716800639,"startTime":"0","endTime":"0","summary":"证券之星消息,戴维医疗05月27日在投资者关系平台上答复投资者关心的问题。谢谢戴维医疗董秘:您好,公司将持续关注监管部门最新发布的各项法律法规、规范性文件,进行深入研究学习,同时,公司将按照相关要求与规则及时、准确、完整地履行信息披露义务,感谢您的关注。谢谢戴维医疗董秘:您好,截止到2024年5月20日,公司股东总户数约为20400户左右,感谢您的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700020318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0042","300314","BK0048","BK0046"],"gpt_icon":0},{"id":"2438050528","title":"戴维医疗(300314)5月20日股东户数2.04万户,较上期增加16.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438050528","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438050528?lang=zh_cn&edition=full","pubTime":"2024-05-27 17:02","pubTimestamp":1716800571,"startTime":"0","endTime":"0","summary":"证券之星消息,近日戴维医疗披露,截至2024年5月20日公司股东户数为2.04万户,较3月31日增加2906.0户,增幅为16.61%。在医疗器械行业个股中,戴维医疗股东户数低于行业平均水平,截至5月20日,医疗器械行业平均股东户数为2.08万户。从股价来看,2024年3月31日至2024年5月20日,戴维医疗区间涨幅为16.73%,在此期间股东户数增加2906.0户,增幅为16.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700020073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0042","300314","BK0251","BK0046"],"gpt_icon":0},{"id":"2436124872","title":"戴维医疗涨8.75%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2436124872","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436124872?lang=zh_cn&edition=full","pubTime":"2024-05-20 16:20","pubTimestamp":1716193223,"startTime":"0","endTime":"0","summary":"今日戴维医疗涨8.75%,收盘报13.05元。2024年4月10日,开源证券研究员余汝意,司乐致发布了对戴维医疗的研报《公司信息更新报告:2023全年业绩符合预期,2024年吻合器依旧放量可期》,该研报对戴维医疗给出“买入”评级。研报中预计2024-2026年归母净利润分别为1.91/2.50/3.26亿元,EPS分别为0.66/0.87/1.13元,当前股价对应P/E分别为17.3/13.2/10.2倍,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为开源证券的司乐致、蔡明子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052000014650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300314","161027"],"gpt_icon":0},{"id":"2436964938","title":"戴维医疗(300314)5月17日主力资金净卖出1225.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2436964938","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436964938?lang=zh_cn&edition=full","pubTime":"2024-05-17 15:26","pubTimestamp":1715930786,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月17日收盘,戴维医疗报收于12.0元,下跌1.72%,换手率3.77%,成交量7.13万手,成交额8579.53万元。5月17日的资金流向数据方面,主力资金净流出1225.75万元,占总成交额14.29%,游资资金净流入18.22万元,占总成交额0.21%,散户资金净流入1207.53万元,占总成交额14.07%。戴维医疗主营业务:提供专业婴儿保育设备解决方案和医疗器械。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051700022165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0048","BK0251","BK0046","300314"],"gpt_icon":0},{"id":"2435362194","title":"戴维医疗:子公司产品获得医疗器械注册证 有利于丰富公司产品线","url":"https://stock-news.laohu8.com/highlight/detail?id=2435362194","media":"中国财富通","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435362194?lang=zh_cn&edition=full","pubTime":"2024-05-16 16:53","pubTimestamp":1715849583,"startTime":"0","endTime":"0","summary":"中国财富通5月16日 - 戴维医疗(300314)公告称,全资子公司宁波维尔凯迪医疗器械有限公司于近日收到浙江省药品监督管理局颁发的《医疗器械注册证》,产品名称一次性使用电动肛肠吻合器。以上产品医疗器械注册证的取得,有利于丰富公司产品线,进一步提高公司的核心竞争力,对公司未来的经营成果将产生积极影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=VFAWPRZ0iIk%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0046","09996","BK0251","BK0048","159883","300314","BK1222","BK0042","BK1574","09997","BK1583","BK1100"],"gpt_icon":0},{"id":"2435257406","title":"戴维医疗最新公告:全资子公司一次性使用电动肛肠吻合器获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2435257406","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435257406?lang=zh_cn&edition=full","pubTime":"2024-05-16 16:21","pubTimestamp":1715847667,"startTime":"0","endTime":"0","summary":"戴维医疗公告,全资子公司维尔凯迪于近日收到浙江省药品监督管理局颁发的《医疗器械注册证》,产品名称为一次性使用电动肛肠吻合器,适用于选择性切除直肠齿状线上粘膜和粘膜下组织,恢复直肠下段正常解剖结构,供齿状线上黏膜选择性切除用。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051600023526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK0042","300314","BK1574","BK0048","BK1100","159883","BK1222","BK0251","BK1583","09997","BK0046"],"gpt_icon":0},{"id":"2435623658","title":"戴维医疗(300314.SZ)子公司维尔凯迪取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2435623658","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435623658?lang=zh_cn&edition=full","pubTime":"2024-05-16 15:49","pubTimestamp":1715845781,"startTime":"0","endTime":"0","summary":"智通财经APP讯,戴维医疗(300314.SZ)公告,公司全资子公司宁波维尔凯迪医疗器械有限公司(简称“维尔凯迪”)于近日收到浙江省药品监督管理局颁发的《医疗器械注册证》,产品名称为:一次性使用电动肛肠吻合器。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1121951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1100","BK1222","09997","159883","BK0251","09996","BK0042","BK0046","300314","BK0048","BK1583"],"gpt_icon":0},{"id":"2435968842","title":"戴维医疗(300314)5月15日主力资金净卖出995.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435968842","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435968842?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:28","pubTimestamp":1715758133,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月15日收盘,戴维医疗报收于12.34元,下跌2.68%,换手率4.66%,成交量8.83万手,成交额1.1亿元。5月15日的资金流向数据方面,主力资金净流出995.65万元,占总成交额9.07%,游资资金净流出420.45万元,占总成交额3.83%,散户资金净流入1416.1万元,占总成交额12.9%。戴维医疗主营业务:提供专业婴儿保育设备解决方案和医疗器械。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500022539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0042","300314","BK0251","BK0046"],"gpt_icon":0},{"id":"2435885591","title":"戴维医疗:公司参股子公司希瑞科技所从事的是干细胞存储行业,主要涉及新生儿脐带、胎盘干细胞的储存服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2435885591","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435885591?lang=zh_cn&edition=full","pubTime":"2024-05-14 19:02","pubTimestamp":1715684541,"startTime":"0","endTime":"0","summary":"证券之星消息,戴维医疗(300314)05月14日在投资者关系平台上答复投资者关心的问题。投资者:董秘您好,请问参股公司希瑞科技业务涉及再生医学吗?目前有没有相关应用?戴维医疗董秘:您好!公司参股子公司希瑞科技所从事的是干细胞存储行业,主要涉及新生儿脐带、胎盘干细胞的储存服务。感谢您的关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400028180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0251","BK0048","300314","BK0042"],"gpt_icon":0},{"id":"2433111977","title":"戴维医疗创60日新高,开源证券四周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2433111977","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433111977?lang=zh_cn&edition=full","pubTime":"2024-05-08 16:22","pubTimestamp":1715156570,"startTime":"0","endTime":"0","summary":"今日戴维医疗创60日新高,收盘报13.82元。2024年4月10日,开源证券研究员余汝意,司乐致发布了对戴维医疗的研报《公司信息更新报告:2023全年业绩符合预期,2024年吻合器依旧放量可期》,该研报对戴维医疗给出“买入”评级。研报中预计2024-2026年归母净利润分别为1.91/2.50/3.26亿元,EPS分别为0.66/0.87/1.13元,当前股价对应P/E分别为17.3/13.2/10.2倍,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为开源证券的司乐致、蔡明子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800027432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300314"],"gpt_icon":0},{"id":"2433150077","title":"5月8日戴维医疗涨停分析:干细胞,基因测序,医疗器械概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433150077","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433150077?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:35","pubTimestamp":1715153727,"startTime":"0","endTime":"0","summary":"证券之星消息,戴维医疗涨停收盘,收盘价13.82元。该股于9点31分涨停,1次打开涨停,截止收盘封单资金为3973.8万元,占其流通市值1.52%。5月8日的资金流向数据方面,主力资金净流入7809.03万元,占总成交额25.03%,游资资金净流出5065.65万元,占总成交额16.24%,散户资金净流出2743.39万元,占总成交额8.79%。近5日资金流向一览见下表:该股为干细胞,基因测序,医疗器械概念热股,当日干细胞概念上涨7.43%,基因测序概念上涨2.2%,医疗器械概念上涨0.95%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800022381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1222","300314","09996","BK0251","BK1583","BK1574","09997","BK0048","BK0046","BK1100","BK0042"],"gpt_icon":0},{"id":"2433766955","title":"异动快报:戴维医疗(300314)5月8日9点31分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2433766955","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433766955?lang=zh_cn&edition=full","pubTime":"2024-05-08 09:35","pubTimestamp":1715132142,"startTime":"0","endTime":"0","summary":"证券之星5月8日盘中消息,9点31分戴维医疗触及涨停板。目前价格13.82,上涨19.97%。其所属行业医疗器械目前上涨。领涨股为宝莱特。该股为干细胞,基因测序,医疗器械概念热股,当日干细胞概念上涨5.84%,基因测序概念上涨2.17%,医疗器械概念上涨1.72%。5月7日的资金流向数据方面,主力资金净流出658.99万元,占总成交额13.2%,游资资金净流出138.37万元,占总成交额2.77%,散户资金净流入797.36万元,占总成交额15.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800014854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300314","BK0042","BK0048","BK0251"],"gpt_icon":0},{"id":"2429977438","title":"戴维医疗获得发明专利授权:“一种冷冻装置及医用压缩机”","url":"https://stock-news.laohu8.com/highlight/detail?id=2429977438","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429977438?lang=zh_cn&edition=full","pubTime":"2024-04-23 02:16","pubTimestamp":1713809765,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示戴维医疗新获得一项发明专利授权,专利名为“一种冷冻装置及医用压缩机”,专利申请号为CN201910773236.1,授权日为2024年4月23日。今年以来戴维医疗新获得专利授权1个,与去年同期持平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300003639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0251","BK0048","300314","BK0042"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2012-05-08","address":"浙江省宁波市象山县石浦科技园区科苑路2号","stockEarnings":[{"period":"1week","weight":-0.0027},{"period":"1month","weight":-0.111},{"period":"3month","weight":-0.0858},{"period":"6month","weight":-0.2286},{"period":"1year","weight":-0.4706},{"period":"ytd","weight":-0.2754}],"companyName":"宁波戴维医疗器械股份有限公司","boardCode":"AI0035","perCapita":"9282股","boardName":"专用设备制造业","registeredCapital":"28800万元","compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":-0.028},{"period":"3month","weight":-0.0072},{"period":"6month","weight":0.0306},{"period":"1year","weight":-0.0677},{"period":"ytd","weight":0.0194}],"survey":" 宁波戴维医疗器械股份有限公司主营业务为儿产科保育设备以及微创外科手术器械。公司主要产品为婴儿培养箱、婴儿辐射保暖台、新生儿黄疸治疗设备、黄疸检测设备、微创外科手术器械。公司被国家工信部认定为“制造业单项冠军培育企业”。公司是国内同行业首批通过CMDC认证、CE认证的企业之一,多项产品在国内外展会获奖,“婴儿培养箱输氧控制技术”、“高精度可控湿度技术”、“婴儿培养箱低噪音技术”和“光照治疗温度控制合成技术”等技术均为国内领先或国内首创。","serverTime":1718611315263,"listedPrice":20,"stockholders":"20400人(较上一季度增加16.61%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"戴维医疗(300314)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供戴维医疗(300314)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"戴维医疗,300314,戴维医疗股票,戴维医疗股票老虎,戴维医疗股票老虎国际,戴维医疗行情,戴维医疗股票行情,戴维医疗股价,戴维医疗股市,戴维医疗股票价格,戴维医疗股票交易,戴维医疗股票购买,戴维医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"戴维医疗(300314)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供戴维医疗(300314)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}